The relationship of energy-restricted diet with FTO and MC4R gene polymorphism in patients with polycystic ovary syndrome
Abstract
Purpose: The aim of this study was to determine whether the effects of an energy-restricted diet on overweight/obese patients with PCOS on body composition and biochemical parameters in groups with MC4R rs17782313 and FTO rs9939609 polymorphisms differ from those without gene polymorphism.
Materials and Methods: A total of 48 women aged 18-45 were accepted. An 8-week diet intervention was applied, and anthropometric measurements, biochemical parameters and food consumption of the patients were determined before and after the intervention. In addition, FTO gene rs9939609 and MC4R gene rs17782313 polymorphisms were determined.
Results: The incidence of FTO and MC4R gene polymorphism was 72.9% and 68.8% respectively. Change in waist/height ratio was found to be higher in the group without FTO gene polymorphism (-0.03±0.015 cm) compared to the group with gene polymorphism (-0.02 ±0.016 cm). There was no statistically significant difference between the groups with and without MC4R gene polymorphism in terms of change (Δ) in anthropometric measurements. Although not statistically significant, there was a greater decrease in body weight (kg) and BMI (kg/m2) in the group without MC4R gene polymorphism compared to the group with it (without polymorphism group -2.2±1.83 kg; -0.9±0.69 kg/m2). There was no statistically significant difference between the groups with and without gene polymorphism in terms of biochemical parameters.
Conclusion: We found that the energy-restricted weight loss diet did not detect a statistically significant change in biochemical parameters in the FTO and MC4R gene polymorphism groups, but the presence of gene polymorphism made it difficult to improve in anthropometric measurements.
Keywords
Ethical Statement
Bu çalışma için; Aydın Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dekanlığı Etik Kurulu’nun 9.1.2019 tarihli ve 92340882-050.04.04 sayılı Kurul Onayı alınmıştır.
References
- Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6:1-13.
- Yıldız BO, Bozdağ G, Yapıcı Z, Esinler I, Yaralı H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067-73.
- Aydos A, Öztemur Y, Bala G. Polycystic ovary syndrome and molecular approaches. Turk Hij Den Biyol Derg. 2016;73:81-8.
- Dai HJ, Wu JCY, Tsai RTH, Pan WH, Hsu WL. T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes. Database (Oxford). 2013;2013:bas061.
- Castro GV, Latorre AFS, Korndorfer FP, de Carlos Back LK, Lofgren SE. The impact of variants in four genes: MC4R, FTO, PPARG and PPARGC1A in overweight and obesity in a large sample of the Brazilian population. Biochem Genet. 2021;59:1666-79.
- Takahashi I, Ohseto H, Ueno F, Onuma T, Narita A, Obara T et al. Genome genome-wide association study based on clustering by obesity-related variables shed light on a genetic architecture of obesity in the Japanese and UK population. medRxiv, 2023;doi: 10.1101/2023.03.06.23286876.
- Batarfi AA, Filimban N, Bajouh OS, Dallol A, Chaudhary AG, Bakhashab S. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia. BMC Med Genet. 2019;20:144.
- Almawi WY, Nemr R, Atazhanova T, Malalla ZH, Sarray S, Mustafa FE et al. Differential association of FTO gene variants and haplotypes with the susceptibility to polycystic ovary syndrome according to obesity in women with PCOS. Reprod Sci. 2023;30:2166-76.
- Branavan U, Muneeswaran K, Wijesundera S, Jayakody S, Chandrasekharan V, Wijeyaratne C. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques. PloS One. 2018;13:0209830.
- Yuan H, Zhu G, Wang F, Wang X, Guo H, Shen M. Interaction between common variants of FTO and MC4R is associated with risk of PCOS. Reprod Biol Endocrinol. 2015;13:55.
